About K.R. (Kevin) Doornhof
Kevin is currently working on his PhD research on the use of medical dosimetry in the optimisation of radioligand therapies. Since 2022, he has worked as a pharmacist at the department of radiology & nuclear medicine.
Currently, his projects focus on improving the use of medical imaging in the treatment of Metastatic castration-resistant prostate cancer (mCRPC).- Radioligand therapy;
- Medical Dosimetry.
-
MSc Pharmacy, RUG, Groningen.
-
BSc Pharmacy, RUG, Groningen.
A complete overview of publications can be found on Pubmed.
